MARIA CRIPPEN: Open Payments
NPI 1588963342 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 14 payments from 8 companies in 2025. Trend: 2023 $598 · 2024 $321 · 2025 $367
Food & beverage: $267Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $125 |
| Exeltis, USA Inc. | 3 | $69 |
| Lilly USA, LLC | 2 | $37 |
| MILLICENT US INC | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $32 |
| Organon LLC | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: SLYND, ZEPBOUND, NEXPLANON, Veozah, Mirena, MYFEMBREE, FEMLYV, INTRAROSA.
Industry payments across VA — which companies pay providers there.
